There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not diagnosed until ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

This year has seen several biopharma companies drop Alzheimer’s and Parkinson’s disease programs, but experts say plenty are ...

Geroscience has a long way to go, but there are four FDA-approved drugs that have shown promise to “target the process of ...

A 65-year-old retired nurse said she had got her life back thanks to a new drug used to treat Parkinson's disease which controls tremors. Jan Fuller, who lives in Hopton-on-Sea near Great Yarmouth ...

There’s a rare point of agreement among Republican and Democratic candidates this election year: America has a drug problem and it’s fentanyl traffickers’ fault. Republicans, including ...

Spanning nearly 100 laboratories in 45 countries, landmark research has, for the first time, shown an association between genetic brain size and neurological conditions such as Parkinson's disease ...